# Nuclear VAV1 increases GLI1-dependent transcription in pancreatic cancer cells

**Authors:** Brooke R. Tader, Luciana L. Almada, Murat Toruner, Kayla C. LaRue-Nolan, David L. Marks, Ashley N. Sigafoos, Laura Hilario-Garcia, Vladimir G. Gainullin, Daniel D. Billadeau, Martin E. Fernandez-Zapico

PMC · DOI: 10.1016/j.jbc.2025.110988 · 2025-11-26

## TL;DR

This study shows that nuclear VAV1 promotes cancer growth in pancreatic cells by enhancing GLI1 activity and BCL2 expression.

## Contribution

The study reveals a novel role for nuclear VAV1 in regulating GLI1-dependent transcription in pancreatic cancer.

## Key findings

- Nuclear VAV1 increases GLI transcriptional activity without changing GLI factor expression.
- VAV1 interacts with GLI1 and is required for BCL2 expression and promoter activity.
- VAV1 is necessary for GLI1 and PCAF binding to the BCL2 promoter region.

## Abstract

The oncogenic role of VAV1, a GTPase guanine nucleotide exchange factor (GEF) with cytoplasmic and nuclear localizations, has been previously reported in multiple malignancies. Most of the mechanisms underlying this pro-tumoral activity have been linked to the cytoplasmic expression of this GEF. To date, the contribution of nuclear VAV1 to cancer development remains poorly understood. Here, using models of pancreatic ductal adenocarcinomas (PDAC), the most common subtype of pancreatic cancer, we provide evidence of a novel mechanism driving oncogenic gene expression in PDAC cells that is regulated by nuclear VAV1. We show that VAV1 wild-type, unlike its mutant lacking the nuclear localization signal (NLS), localizes to the nucleus of PDAC cells where it increases GLI transcriptional activity without affecting the expression of GLI factors (GLI1, GLI2 and GLI3). Interestingly, this VAV1 NLS-deficient mutant loses interaction with Importin b1 but maintains ability to activate RAC1. Further analysis showed that VAV1 and GLI1 endogenously interact in PDAC cells, and knockdown of VAV1 reduces the expression of a set of GLI target genes including BCL2. We found VAV1 bound to the GLI binding motif present within the BCL2 promoter region and demonstrate the requirement of VAV1 to maintain BCL2 expression and promoter activity. Finally, we showed that VAV1 is necessary for the binding of GLI1 and its coactivator the histone acetyltransferase PCAF to this regulatory element. Taken together, our data supports a role for VAV1 in GLI1 transcriptional regulation, elucidating a new mechanism of function for nuclear VAV1 in PDAC cells.

## Linked entities

- **Genes:** VAV1 (vav guanine nucleotide exchange factor 1) [NCBI Gene 7409], GLI1 (GLI family zinc finger 1) [NCBI Gene 2735], GLI2 (GLI family zinc finger 2) [NCBI Gene 2736], GLI3 (GLI family zinc finger 3) [NCBI Gene 2737], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], RAC1 (Rac family small GTPase 1) [NCBI Gene 5879], KAT2B (lysine acetyltransferase 2B) [NCBI Gene 8850]
- **Proteins:** VAV1 (vav guanine nucleotide exchange factor 1), GLI1 (GLI family zinc finger 1), GLI2 (GLI family zinc finger 2), GLI3 (GLI family zinc finger 3), BCL2 (BCL2 apoptosis regulator), RAC1 (Rac family small GTPase 1), KAT2B (lysine acetyltransferase 2B)
- **Diseases:** pancreatic cancer (MONDO:0005192), pancreatic ductal adenocarcinoma (MONDO:0005184)

## Full-text entities

- **Genes:** KAT2B (lysine acetyltransferase 2B) [NCBI Gene 8850] {aka CAF, P/CAF, PCAF}, VAV1 (vav guanine nucleotide exchange factor 1) [NCBI Gene 7409] {aka VAV}, RAC1 (Rac family small GTPase 1) [NCBI Gene 5879] {aka MIG5, MRD48, Rac-1, TC-25, p21-Rac1}, GLI1 (GLI family zinc finger 1) [NCBI Gene 2735] {aka GLI, PAPA8, PPD1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, GLI2 (GLI family zinc finger 2) [NCBI Gene 2736] {aka CJS, HPE9, PHS2, THP1, THP2}, GLI3 (GLI family zinc finger 3) [NCBI Gene 2737] {aka ACLS, GCPS, GLI3-190, GLI3FL, PAP-A, PAPA}
- **Diseases:** pancreatic cancer (MESH:D010190), PDAC (MESH:D021441), cancer (MESH:D009369)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12765065/full.md

---
Source: https://tomesphere.com/paper/PMC12765065